Parabilis Medicines, Inc.
PBLS
IPO
$37.07
$1.403.93%
NASDAQ
IPO Factors
Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation
Headlines
8/14/2026
-
TipRanks
8/14/2026
-
Seeking Alpha - Healthcare
8/14/2026
-
Seeking Alpha - Long Ideas
8/13/2026
-
TipRanks
8/13/2026
-
Globe Newswire
8/10/2026
-
MarketBeat
8/1/2026
-
MarketBeat
7/18/2026
-
TipRanks
7/16/2026
-
TipRanks: TheFly
7/14/2026
-
MarketBeat
7/13/2026
-
TipRanks
7/13/2026
-
MarketBeat
7/9/2026
-
The Cerbat Gem
7/9/2026
-
MarketBeat
7/8/2026
-
The Cerbat Gem
7/6/2026
-
TipRanks
7/6/2026
-
TipRanks: TheFly
7/6/2026
-
The Cerbat Gem
7/6/2026
-
24/7 Wall St.
7/6/2026
-
TipRanks: TheFly
7/6/2026
-
Benzinga
7/6/2026
-
TipRanks: TheFly
7/1/2026
-
The Cerbat Gem
6/28/2026
-
Insider Monkey
6/28/2026
-
Fool.com Headlines
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, May 19, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of May 17 and 21 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(617) 945-9510
Address
30 Acorn Park Drive
Cambridge, MA 02140
Cambridge, MA 02140
Country
Year Founded
Business Description
Sector
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical...
more